News Image

Why NASDAQ:PGNY Is a Standout High-Growth Stock in a Consolidation Phase.

By Mill Chart

Last update: Jan 26, 2024

In this article, we'll take a closer look at PROGYNY INC (NASDAQ:PGNY) as a potential candidate for growth investing. While it's important for investors to conduct their own research, PROGYNY INC has piqued our interest by appearing on our strong growth and breakout radar. Let's explore further.

Unpacking NASDAQ:PGNY's Growth Rating

Every stock receives a Growth Rating from ChartMill, ranging from 0 to 10. This rating assesses various growth aspects, including historical and projected EPS and revenue growth. NASDAQ:PGNY boasts a 8 out of 10:

  • The Earnings Per Share has grown by an impressive 23.81% over the past year.
  • The Revenue has grown by 47.53% in the past year. This is a very strong growth!
  • The Revenue has been growing by 74.52% on average over the past years. This is a very strong growth!
  • PGNY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 45.53% yearly.
  • Based on estimates for the next years, PGNY will show a very strong growth in Revenue. The Revenue will grow by 22.58% on average per year.

Looking at the Health

ChartMill employs a unique Health Rating system for all stocks. This rating, ranging from 0 to 10, is determined by analyzing various liquidity and solvency ratios. For NASDAQ:PGNY, the assigned 8 for health provides valuable insights:

  • PGNY has an Altman-Z score of 12.77. This indicates that PGNY is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of PGNY (12.77) is better than 97.39% of its industry peers.
  • PGNY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
  • A Current Ratio of 3.16 indicates that PGNY has no problem at all paying its short term obligations.
  • PGNY's Current ratio of 3.16 is amongst the best of the industry. PGNY outperforms 89.57% of its industry peers.
  • PGNY has a Quick Ratio of 3.16. This indicates that PGNY is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 3.16, PGNY belongs to the best of the industry, outperforming 89.57% of the companies in the same industry.

How do we evaluate the Profitability for NASDAQ:PGNY?

ChartMill's Profitability Rating offers a unique perspective on stock analysis, providing scores from 0 to 10. These ratings consider a wide range of profitability metrics and margins, both in comparison to industry peers and on their own merits. For NASDAQ:PGNY, the assigned 6 is a significant indicator of profitability:

  • PGNY has a Return On Assets of 7.16%. This is amongst the best in the industry. PGNY outperforms 87.83% of its industry peers.
  • PGNY has a Return On Equity of 10.09%. This is in the better half of the industry: PGNY outperforms 75.65% of its industry peers.
  • The Return On Invested Capital of PGNY (7.66%) is better than 78.26% of its industry peers.
  • The 3 year average ROIC (6.26%) for PGNY is below the current ROIC(7.66%), indicating increased profibility in the last year.
  • Looking at the Profit Margin, with a value of 5.03%, PGNY belongs to the top of the industry, outperforming 82.61% of the companies in the same industry.
  • PGNY has a better Operating Margin (5.00%) than 65.22% of its industry peers.
  • PGNY's Gross Margin has improved in the last couple of years.

How do we evaluate the setup for NASDAQ:PGNY?

Besides the Technical Rating, ChartMill also assign a Setup Rating to every stock. This setup score also ranges from 0 to 10 and determines to which extend the stock is consolidating. This is achieved by evaluating multiple short term technical indicators. NASDAQ:PGNY currently has a 8 as setup rating:

Besides having an excellent technical rating, PGNY also presents a decent setup pattern. We see reduced volatility while prices have been consolidating in the most recent period. A pullback is taking place, which may present a nice opportunity for an entry. There is a resistance zone just above the current price starting at 37.91. Right above this resistance zone may be a good entry point. There is a support zone below the current price at 36.29, a Stop Loss order could be placed below this zone.

Every day, new Strong Growth stocks can be found on ChartMill in our Strong Growth screener.

Check the latest full fundamental report of PGNY for a complete fundamental analysis.

For an up to date full technical analysis you can check the technical report of PGNY

Keep in mind

This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.

Back

PROGYNY INC

NASDAQ:PGNY (4/18/2024, 7:13:59 PM)

Premarket: 31.77 -0.11 (-0.35%)

31.88

-0.87 (-2.66%)

PGNY News

News Image15 days ago - ProgynyProgyny and RESOLVE to Honor National Infertility Awareness Week® with Events Spanning Coast to Coast

The leading benefits solution and largest infertility advocacy non-profit will host a series of events aimed at raising awareness for the millions of individuals facing family building challenges

News Image15 days ago - ProgynyProgyny and RESOLVE to Honor National Infertility Awareness Week® with Events Spanning Coast to Coast

The leading benefits solution and largest infertility advocacy non-profit will host a series of events aimed at raising awareness for the millions of...

News Imagea month ago - ProgynyProgyny, Inc. to Present at KeyBanc Life Sciences & MedTech Investor Forum

NEW YORK, March 18, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits...

News Imagea month ago - InvestorPlaceThe 7 Most Undervalued Mid-Cap Stocks to Buy in March 2024

Wager on these top undervalued mid-cap stocks, effectively blending growth and value, with a remarkable broader-market performance in 2023.

News Imagea month ago - BusinessInsiderThe 7 Most Undervalued Mid-Cap Stocks to Buy in March 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Wagering on mid-cap stocks can potentially unlock investment treasures typicall...

News Imagea month ago - ProgynyProgyny, Inc. to Present at Barclays 26th Annual Global Healthcare Conference

NEW YORK, March 11, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits...

News Image2 months ago - Seeking AlphaProgyny announces $100M share repurchase program (NASDAQ:PGNY)

Progyny (PGNY) approves $100 million share repurchase program funded by available cash balances.

News Image2 months ago - ProgynyProgyny, Inc. Announces Share Repurchase Program
News Image2 months ago - ProgynyProgyny, Inc. Announces Share Repurchase Program

NEW YORK, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits...

News Image2 months ago - Market News VideoWednesday Sector Laggards: Hospital & Medical Practitioners, Oil & Gas Refining & Marketing Stocks
News Image2 months ago - ProgynyProgyny, Inc. Announces Fourth Quarter 2023 Results
News Image2 months ago - ProgynyProgyny, Inc. Announces Fourth Quarter 2023 Results

Reports Record Full Year Revenue of $1,088.6 Million, Reflecting 38% GrowthAchieves 49% Growth in Adjusted EBITDA to Record $187.1 MillionIssues Financial Guidance for 2024, Crossing the $1.3 Billion Milestone at Midpoint

PGNY Links
Follow us for more